Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,987	1,505	1,533	1,081	909	238
Market Cap Growth	39.89%	-1.81%	41.76%	18.95%	281.43%	115.61%
Enterprise Value	1,520	929	1,049	655	636	179
PE Ratio	-	-7.19	-10.26	43.38	-11.79	-4.25
PS Ratio	-	-	-	7.74	599.16	157.08
PB Ratio	3.99	2.72	3.28	2.65	3.60	7.54
P/FCF Ratio	-9.87	-9.37	-11.49	37.28	-12.76	-4.71
P/OCF Ratio	-9.87	-9.37	-11.47	37.11	-12.76	-4.71
EV/Sales Ratio	-	-	-	4.69	419.44	118.27
EV/EBITDA Ratio	-6.60	-4.46	-7.20	24.02	-8.58	-3.23
EV/EBIT Ratio	-6.57	-4.44	-7.18	24.43	-8.52	-3.20
EV/FCF Ratio	-7.71	-5.78	-7.86	22.59	-8.93	-3.54
Debt / Equity Ratio	0.00	0.00	0.00	0.05	0.08	0.03
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	0.77	-0.28	-0.02
Debt / FCF Ratio	-0.01	-0.01	-0.01	0.72	-0.29	-0.02
Quick Ratio	8.85	9.95	16.79	21.61	15.54	3.25
Current Ratio	8.93	10.00	16.85	21.68	15.84	3.39
Asset Turnover	0	0	0	0.45	0.01	0.02
Interest Coverage	-1078.08	-1005.54	-46.61	14.13	-31.70	-
Return on Equity (ROE)	-53.30%	-47.90%	-38.70%	9.50%	-52.70%	-112.40%
Return on Assets (ROA)	-48.50%	-44.00%	-35.40%	8.10%	-39.60%	-68.60%
Return on Capital (ROIC)	-53.41%	-41.37%	-32.38%	6.11%	-26.19%	-177.06%
Earnings Yield	-12.27%	-13.91%	-9.74%	2.31%	-8.48%	-23.52%
FCF Yield	-10.45%	-10.67%	-8.71%	2.68%	-7.84%	-21.24%
Buyback Yield / Dilution	-22.72%	-15.82%	-13.31%	-29.81%	-35.48%	-20.18%
Total Shareholder Return	-22.72%	-15.82%	-13.31%	-29.81%	-35.48%	-20.18%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).